Latest Bone Cancer News | Feature Articles, Bone Cancer Research

Bone Cancer News

BONE CANCER ADVISOR

Bone Cancer News

Pomalyst Approved for Multiple Myeloma

Celgene announced that the FDA has approved Pomalyst (pomalidomide) for the treatment of patients with relapsed and/or refractory multiple myeloma.